×
About 90 results

ALLMedicine™ Amyloid Neuropathy Center

Research & Reviews  33 results

Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.
https://doi.org/10.1016/j.jns.2022.120341
Journal of the Neurological Sciences; Thimm A, Carpinteiro A et. al.

Jul 26th, 2022 - Immunoglobulin light chain (AL) amyloidosis is a life-threatening systemic disease due to plasma cell dyscrasias, which is characterized by amyloid deposition in various tissues. Neurological manifestations, in particular peripheral nervous system...

Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology
https://clinicaltrials.gov/ct2/show/NCT03190577

Jul 14th, 2022 - Familial amyloid neuropathy due to transthyretin gene mutations (TTR-FAP) is a rare autosomal dominant inherited disease resulting in the abnormal multi-system deposition of amyloid proteins. These deposits produce a multi-organ disease. AP is usu...

Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)
https://clinicaltrials.gov/ct2/show/NCT04828928

Jul 6th, 2022 - Transthyretin (TTR) amyloidosis belongs to a group of severe and multi-systemic diseases caused by an extracellular accumulation of fibrillar proteins arranged in beta-pleated sheets. This pathology can be hereditary (mutations in the TTR gene) or...

Magnetic resonance imaging of dorsal root ganglion in a pre-symptomatic subject with fa...
https://doi.org/10.1016/j.jns.2022.120329
Journal of the Neurological Sciences; Murakami T, Watanabe H et. al.

Jul 2nd, 2022 - We recently reported evidence of transthyretin (TTR) familial amyloid polyneuropathy (TTR FAP) associated with TTR E61K, which is characterized by late-onset sensory dominant polyneuropathy, autonomic disturbances, and cardiomyopathy. In those TTR...

Treatment With Diflunisal in Domino Liver Transplant Recipients With Acquired Amyloid N...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044119
Transplant International : Official Journal of the Europe... Nedkova-Hristova V, Baliellas C et. al.

May 3rd, 2022 - Objectives: To analyze the efficacy and tolerability of diflunisal for the treatment of acquired amyloid neuropathy in domino liver transplant recipients. Methods: We performed a retrospective longitudinal study of prospectively collected data for...

see more →

Clinicaltrials.gov  3 results

Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology
https://clinicaltrials.gov/ct2/show/NCT03190577

Jul 14th, 2022 - Familial amyloid neuropathy due to transthyretin gene mutations (TTR-FAP) is a rare autosomal dominant inherited disease resulting in the abnormal multi-system deposition of amyloid proteins. These deposits produce a multi-organ disease. AP is usu...

Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)
https://clinicaltrials.gov/ct2/show/NCT04828928

Jul 6th, 2022 - Transthyretin (TTR) amyloidosis belongs to a group of severe and multi-systemic diseases caused by an extracellular accumulation of fibrillar proteins arranged in beta-pleated sheets. This pathology can be hereditary (mutations in the TTR gene) or...

Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
https://clinicaltrials.gov/ct2/show/NCT03588468

Jul 18th, 2018 - Familial amyloid neuropathies (FAP) are hereditary disease due to a mutation of the tranthyretin gene (TTR). These neuropathies are severe and life frightening. Treatment is based on tafamidis and liver transplantation. Clinical trials of RNAI the...

see more →